K.J. Walker

572 total citations
18 papers, 394 citations indexed

About

K.J. Walker is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Reproductive Medicine. According to data from OpenAlex, K.J. Walker has authored 18 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Genetics and 4 papers in Reproductive Medicine. Recurrent topics in K.J. Walker's work include Estrogen and related hormone effects (9 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Hypothalamic control of reproductive hormones (4 papers). K.J. Walker is often cited by papers focused on Estrogen and related hormone effects (9 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Hypothalamic control of reproductive hormones (4 papers). K.J. Walker collaborates with scholars based in United Kingdom. K.J. Walker's co-authors include Robert I. Nicholson, A. Turkes, R.W. Blamey, Michael R. Williams, P.N. Plowman, K. Griffiths, R.W. Blamey, R.I. Nicholson, Kate Griffiths and Ian O. Ellis and has published in prestigious journals such as The Lancet, Annals of the New York Academy of Sciences and British Journal of Cancer.

In The Last Decade

K.J. Walker

17 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K.J. Walker United Kingdom	11	208	128	97	96	83	18	394
R.J. Zaino United States	9	290 1.4×	125 1.0×	29 0.3×	182 1.9×	59 0.7×	14	537
AL Tesdale United Kingdom	10	182 0.9×	137 1.1×	25 0.3×	124 1.3×	101 1.2×	13	344
P Cohen United States	9	131 0.6×	97 0.8×	23 0.2×	60 0.6×	57 0.7×	20	347
Anthony C. Evans United States	11	145 0.7×	118 0.9×	30 0.3×	113 1.2×	66 0.8×	14	517
Nancy F. Fritz United States	7	359 1.7×	237 1.9×	75 0.8×	83 0.9×	152 1.8×	8	505
Thomas K. Barton United States	8	219 1.1×	112 0.9×	22 0.2×	94 1.0×	104 1.3×	9	433
P Westin Sweden	8	65 0.3×	95 0.7×	69 0.7×	46 0.5×	80 1.0×	9	395
Snježana Frković Grazio Slovenia	13	68 0.3×	96 0.8×	34 0.4×	59 0.6×	53 0.6×	23	323
T Hägerström Sweden	9	73 0.4×	120 0.9×	59 0.6×	17 0.2×	67 0.8×	11	297
Sonia Godoy‐Tundidor Austria	12	122 0.6×	183 1.4×	55 0.6×	21 0.2×	161 1.9×	14	547

Countries citing papers authored by K.J. Walker

Since Specialization

Citations

This map shows the geographic impact of K.J. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.J. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.J. Walker more than expected).

Fields of papers citing papers by K.J. Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.J. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.J. Walker. The network helps show where K.J. Walker may publish in the future.

Co-authorship network of co-authors of K.J. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of K.J. Walker. A scholar is included among the top collaborators of K.J. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.J. Walker. K.J. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

McClurg, Doreen, et al.. (2021). Studying the Effects of Clean Intermittent Self-Catheterization on the Quality of Life and Anxiety of Patients. 2(2). 22–29.

McClurg, Doreen, et al.. (2018). Participant experiences of clean intermittent self-catheterisation, urinary tract infections and antibiotic use on the ANTIC trial – A qualitative study. International Journal of Nursing Studies. 81. 1–7. 13 indexed citations

Walker, K.J., et al.. (2012). Linezolid-induced hypoglycaemia in a patient with type 1 diabetes. The British Journal of Diabetes. 12(4). 186–188. 1 indexed citations

Craig, Jeffrey W., et al.. (2008). Multifocal primary extranodal B-cell non-Hodgkin’s lymphoma involving six extranodal sites: Figure 1. Journal of Clinical Pathology. 62(1). 89–91. 1 indexed citations

Nicholson, R.I., et al.. (1990). Estrogen Deprivation in Breast Cancer. Annals of the New York Academy of Sciences. 595(1). 316–327. 15 indexed citations

Nicholson, Robert I., K.J. Walker, R A McClelland, et al.. (1990). Zoladex® plus tamoxifen versus zoladex® alone in pre- and peri-menopausal metastatic breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 37(6). 989–995. 17 indexed citations

Robertson, J.F.R., R.I. Nicholson, K.J. Walker, & R.W. Blarney. (1989). Zoladex in Advanced Breast Cancer. Hormone Research. 32(1). 206–208. 5 indexed citations

Walker, K.J., Richard F. Walker, Atilla Turkes, et al.. (1989). Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancer. European Journal of Cancer and Clinical Oncology. 25(4). 651–654. 22 indexed citations

Nicholson, Robert I. & K.J. Walker. (1989). Gn-RH agonists in breast and gynaecologic cancer treatment. Journal of Steroid Biochemistry. 33(4). 801–804. 4 indexed citations

10.

Nicholson, Robert I. & K.J. Walker. (1989). Use of LH-RH agonists in the treatment of breast disease. Proceedings of the Royal Society of Edinburgh Section B Biological Sciences. 95. 271–281. 14 indexed citations

11.

Walker, K.J., J. David Robertson, Ian O. Ellis, et al.. (1988). Immunocytochemical localization of estrogen receptor in human breast tissue.. PubMed. 48(22). 6517–22. 70 indexed citations

12.

Nicholson, Robert I. & K.J. Walker. (1988). Preclinical Studies and Antitumor Mechanism of Action of LHRH Analogues. Cancer treatment and research. 39. 1–23. 2 indexed citations

13.

Buck, A, W.B. Peeling, RC Rees, et al.. (1987). The Treatment of Metastatic Prostatic Cancer with the Slow Release LH‐RH Analogue Zoladex ICI 118630. British Journal of Urology. 59(5). 436–442. 11 indexed citations

14.

Williams, Michael R., K.J. Walker, A. Turkes, R.W. Blamey, & Robert I. Nicholson. (1986). The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer. British Journal of Cancer. 53(5). 629–636. 85 indexed citations

15.

Plowman, P.N., Robert I. Nicholson, & K.J. Walker. (1986). Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630. British Journal of Cancer. 54(6). 903–909. 43 indexed citations

16.

Walker, K.J., A. Turkes, Michael R. Williams, R.W. Blamey, & R.I. Nicholson. (1986). Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist d-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer. Journal of Endocrinology. 111(2). 349–353. 21 indexed citations

17.

Walker, K.J., R.I. Nicholson, A. Turkes, Nicholas Plowman, & R.W. Blamey. (1984). Therapeutic potential of the lh-rh agonist zoladex (ICI 118630) in the treatment of advanced breast cancer in pre and postmenopausal women. Journal of Steroid Biochemistry. 20(6). 1409–1409. 5 indexed citations

18.

Walker, K.J., et al.. (1983). THERAPEUTIC POTENTIAL OF THE LHRH AGONIST, ICI 118630, IN THE TREATMENT OF ADVANCED PROSTATIC CARCINOMA. The Lancet. 322(8347). 413–415. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact